Mesothelioma Specialists
A specialist who regularly treats mesothelioma is aware of what to look out for in blood tests, imaging tests and other diagnostic tools. Specialists in mesothelioma can also provide advanced treatments that could improve the chances of survival.
When selecting a mesothelioma doctor, consider the experience, affiliation with a hospital and availability. Patients must feel comfortable and supported at each visit.
lawton mesothelioma lawsuit . Raja Flores is a mesothelioma specialist with a reputation for excellence, known for his compassion for patients and surgical skills. He is the chief of thoracic surgical at Mount Sinai Medical Center, New York City.
Flores developed his expertise in lung cancer and mesothelioma treatments during his time at Brigham and Women's Hospital, where he was trained by renowned mesothelioma surgeon Dr. David Sugarbaker. He is an expert in treating lung cancer, pleural cancer and esophageal carcinoma.
He helped pioneer the lung-sparing pleurectomy/decortication surgery that has been successfully used as a curative procedure in scores of mesothelioma cases. He also played a key role in the development of video-assisted thoracic surgery (VATS) lobectomy, which is now the treatment for patients suffering from lung cancer. This minimally invasive procedure requires just three small incisions for the removal of cancerous lung sections.
Flores published more than 100 peer-reviewed journal papers and book chapters throughout his career treating mesothelioma. He has received many professional accolades and awards, including being named a New York and America Top Doctor. He has also been involved to several clinical research studies. One of them examined the effectiveness of in mesothelioma neoadjuvant treatment.
A physical examination along with blood tests and imaging can all be used to identify mesothelioma. Patients may not exhibit symptoms until the disease is at an advanced stage. Patients may experience chest, throat or abdomen discomfort, fatigue, coughing, and breathing difficulties. A doctor can drain the excess fluid to determine the presence of cancer cells and determine if a patient has the epitheliod, mixed or sarcomatoid type of mesothelioma.
Asbestos is the main reason for mesothelioma. Those exposed to asbestos during the construction, maintenance and repair of power plants, ships or factories have a higher risk of developing cancer.
A multidisciplinary team can offer patients the best mesothelioma treatment. In addition to the surgeon patients should consult radiation specialists and medical oncologists who specialize in mesothelioma treatment. These specialists can devise plans to treat the cancer with chemotherapy and/or radiation. It is also crucial for mesothelioma patients to ask their doctors how many mesothelioma cases they have treated.
Robert Cameron
A well-known mesothelioma specialist Robert Cameron graduated medical school at UCLA about 30 years ago. Prior to pursuing his mesothelioma-specific training and surgical residency, he completed his surgical residencies in the National Cancer Institute and Cornell University Medical Center. His mesothelioma patients benefit from his expertise in lung-sparing surgery and minimally invasive techniques like thorascopic surgery. Cameron is also a mesothelioma researcher and has published more than 35 papers about thoracic surgery and oncology.
He is the co-founder of Mesothelioma Applied Research Foundation and serves as the scientific advisor for the Pacific Mesothelioma Center. He is also the director of thoracic surgery at both the University of California Los Angeles and West Los Angeles Veterans Affairs Medical Center mesothelioma centers.
Dr. Cameron is a leader in mesothelioma treatments and has helped thousands of asbestos sufferers. He is focused on improving the quality and accessibility of mesothelioma treatments for patients. He is also an active advocate for patients and their family members throughout the treatment process.
Cameron is a mesothelioma specialist with experience in treating both peritoneal and pleural mesothelioma. Cameron is proficient in a variety of surgical mesothelioma treatment options, including cytoreductive surgeries and hyperthermic intraperitoneal chemotherapeutic treatments and pleurectomy/decortication. He has also treated pericardial tumors by surgical removal of tumors within the heart's lining and surrounding tissue.
It is essential to find a mesothelioma specialist with privileges at an institution for cancer that you can trust. A reputable doctor will have the staff, equipment and clinical trials to ensure you receive the treatment you require. It is also essential to bring relevant scans of your imaging and work history records to your appointment. You might also want to bring your family member or a friend along with you for assistance and to help remember important information during your appointment.
If you are not keen on surgery or are unable to undergo it, there are other alternatives for mesothelioma treatment, like immunotherapy and radiation. A lot of mesothelioma specialists are adept in coordinating these additional treatments that involve surgery. The mesothelioma specialists in your cancer center can help you in making these choices following a mesothelioma diagnosis.
Raphael Bueno
Bueno is a specialist in the treatment of thoracic cancers including mesothelioma. He is currently working to improve the way mesothelioma and other lung cancers are treated and diagnosed, as well as treated. Bueno's research is helping doctors to understand mesothelioma at the molecular level. This will aid mesothelioma to be diagnosed and it could lead to new strategies of treatment.
As the Chief of Thoracic Surgery and Vice-Chairman of Surgery for Cancer Research at Brigham and Women's Hospital, Raphael Bueno is committed to maintaining the institution's world-leading position in mesothelioma research and treatment. Bueno is the hospital's director of the International Mesothelioma Program, and he has a wide spectrum of expertise in mesothelioma diagnosis treatment, prevention and treatment.
While the leadership of patient care, and teaching were all important aspects of his professional career but his time at BWH has been focused on research. He has developed tests that aid surgeons in identifying mesothelioma tumors in a surgical biopsy, and is working on methods to make the procedure less and less invasive. He is also researching mesothelioma's gender-specific characteristics, and how tumors grow.
Bueno started working at BWH as a surgical student after he graduated from Harvard Medical School. He learned a lot about mesothelioma through working with Dr. David Sugarbaker. After his internship he completed an cardiothoracic surgical residency at Massachusetts General Hospital. He returned to BWH and established an individual surgery practice as well as a laboratory for mesothelioma.
One of his biggest accomplishments is the invention of iVats. This system allows surgeons to accurately locate mesothelioma tumours and remove them when performing an extrapleural lung pneumonectomy. The method is a significant improvement on the traditional method that is often ineffective and requires more tissue to be removed than necessary. The new method has resulted in better outcomes for patients with mesothelioma.
Bueno is an active participant in a variety of clinical trials to discover innovative ways to improve mesothelioma diagnosis and treatment. He is a Dana-Farber Cancer Institute member and has appointments at Brigham and Women's Faulkner Hospital and Carney Hospital. He is also a fellow of the American College of Chest Physicians.
Paul Sugarbaker
Paul Sugarbaker is a nationally acknowledged mesothelioma specialist who is known for his work on mesothelioma of the peritoneal region and abdominal cancers. His innovative method of treating this rare cancer and pushing the boundaries of treatment helped increase survival rates. He created, perfected and then popularized the method of combining cancer surgery and chemotherapy heated to treat mesothelioma of the peritoneal region. The Sugarbaker procedure is the name given to this method that is unique. He continues to travel around the world to teach young surgeons on this revolutionary procedure.
A mesothelioma specialist has years of experience treating asbestos-related diseases. They may also have experience with the most current mesothelioma treatment, as well as clinical trials. Mesothelioma patients must be prepared for their first visit with mesothelioma specialists by bringing their medical records, a list of questions and a willingness to communicate.

There are different types of mesothelioma doctors and each one will have their own specialty. This includes thoracic surgeons, general surgeons, pulmonologists, pathologists, and radiation oncologists. Each of these mesothelioma specialists plays a crucial role in the care of patients.
A thoracic surgeon can treat tumors and other problems in the chest cavity, including mesothelioma of the pleural cavity. They can perform lung surgeries to eliminate the size of tumors or improve breathing capacity. They may also prescribe medications to treat symptoms or to increase the life expectancy.
A thoracic specialist can assist patients with the most difficult treatment options. They can also assist patients locate mesothelioma support groups and other sources.
Paul Sugarbaker earned his undergraduate degree at Wheaton College, located in Illinois. He completed his residency in surgery in Boston at Peter Bent Brigham Hospital, an affiliated program of Harvard University. He then relocated to Atlanta, Georgia where he worked at Emory University for two years before returning to Washington, D.C.
Paul Sugarbaker, a cancer specialist and surgeon with international repute He is a highly respected surgeon. He was named one of America's Top Doctors and has been an active member of numerous professional associations. He is known for his relentless search for a cure for mesothelioma peritoneal, which has led to the HIPEC (heated intraperitoneal chemotherapy) procedure, which has been shown to prolong the lives of patients with this rare form of cancer.